7 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 7, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow EPO: new trials by email Literature Review of EPO trials Research Report on EPO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. Erythropoietin + Probiotic, EPO - Anaemia, Chronic Kidney Disease | Phase 3 | Completed | Badr University | 80 | 2026-02-01 | 2026-10-30 |
| Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT decitabine, umbilical cord blood, Granulocyte-colony stimulating factor - Poor Graft Function | Phase 3 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 100 | 2023-08-01 | 2023-06-09 |
| Decitabine for Poor Graft Function Post Allo-HSCT Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist - Poor Graft Function | Phase 3 | Completed | The First Affiliated Hospital of Soochow University | 76 | 2023-07-01 | 2026-10-23 |
| Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma recombinant human erythropoietin - Lymphoma, Anemia | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 130 | 2021-04-01 | 2021-08-11 |
| Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) Epo, Control - Extreme Prematurity | Phase 3 | Completed | University of Washington | 941 | 2013-12-01 | 2026-05-19 |
| Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period Ferric carboxymaltose, Erythropoietin, Placebo - Hip Fractures | Phase 3 | Completed | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 303 | 2010-06-01 | 2015-07-28 |
| Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Bone Marrow Biopsy, Epoetin Alfa, Laboratory Biomarker Analysis - Anemia, Chronic Myelomonocytic Leukemia | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 247 | 2009-04-20 | 2026-11-13 |
| REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial erythropoietin - Kidney Failure, Chronic, Drug Resistance | Phase 3 | Terminated | Queen's University | 6 | 2006-10-01 | 2009-02-12 |
| Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis Venofer and stable erythropoietin (EPO) regimen, stable erythropoietin (EPO) regimen - Anemia | Phase 3 | Completed | American Regent, Inc. | 121 | 2002-07-01 | 2021-05-19 |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia External Beam Radiation Therapy, Cisplatin, Internal Radiation Therapy - Anemia, Cervical Adenocarcinoma | Phase 3 | Completed | Gynecologic Oncology Group | 114 | 2001-08-01 | 2017-08-09 |
| Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes Erythropoietin, Filgrastim, Transfusion - Anemia, Myelodysplastic Syndromes | Phase 3 | Completed | Eastern Cooperative Oncology Group | 118 | 1998-03-04 | 2023-06-29 |
Anemia (6) · Myelodysplastic Syndromes (2) · Anemia, Refractory (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hip Fractures (1) · Kidney Failure, Chronic (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Premature Birth (1) · Radiation Injuries (1) · Renal Insufficiency, Chronic (1) · Uterine Cervical Neoplasms (1)
The First Affiliated Hospital of Soochow University (2) · American Regent, Inc. (1) · Badr University (1) · Eastern Cooperative Oncology Group (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Gynecologic Oncology Group (1) · National Cancer Institute (NCI) (1) · Queen's University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Washington (1)
United States (4) · China (2) · Canada (1) · Egypt (1) · Spain (1)
Amit K Verma (1) · Gillian Thomas (1) · Karen E Yeates, MD, FRCP(C), MPH (1) · Kenneth B. Miller, MD (1) · Mark A Falone, MD (1) · Sandra E Juul, MD, PhD (1) · Yue Han (1) · Yue Han, Professor (1)
PMID 16818281, PMID 19564636, PMID 22353604, PMID 26181032, PMID 27057344, PMID 27088376, PMID 27195774, PMID 28821985, PMID 31940698, PMID 32488672, PMID 32804205, PMID 33113526, PMID 33439748, PMID 33646303, PMID 34117080, PMID 34324880, PMID 34492685, PMID 34845352, PMID 35338252, PMID 35725917, PMID 35853728, PMID 36580332, PMID 37561461, PMID 37790304, PMID 37926336, PMID 38195921, PMID 38195922, PMID 39390245, PMID 41214292, PMID 41222934, PMID 42012687
U10CA021115 (2), 2009 (1), U01NS077953 (1), U10CA027469 (1), U10CA180820 (1), U24CA196172 (1)